Biomarker analysis from Phase 1/2 study of tusamitamab ravtansine (SAR408701) in patients with advanced non-small cell lung cancer (NSCLC)Anas Gazzah,Joon Sang Lee,Emma Wang,Nils Ternes,Hong Wang,Eric Boitier,AuDe lartigau,Mustapha Chadjaa,Colette Dib,Gaelle Muzard,Sandrine Valence, Anne Remaury, Cintia C. Palu,Anne-Laure BauchetCANCER RESEARCH(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要